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Introduction 
A randomized clinical trial of close contact casting versus the usual practice of surgery for 
treating unstable ankle fractures in older adults found equivalent ankle function outcomes at 6 
months.1 Higher rates of radiological ankle malunion in the casting vs surgical groups (15% 
vs 3%) and non-union (medial malleolus 7% vs 1%) suggested that equivalence between the 
two groups may be lost if symptoms or functional limitations from posttraumatic arthritis 
manifest later.2 A follow-up at least 3 years after randomization was conducted to determine 
if equivalence persisted over time. 
Methods 
This study was a pre-specified extended follow-up of a pragmatic, multi-center, equivalence, 
randomized clinical trial.1 The National Research Ethics Service Oxfordshire gave approval, 
written informed consent was obtained. Participants were adults aged over 60 years with 
acute unstable malleolar fracture(s) from 24 UK centers. Participants had received surgery 
(usual local practice internal fixation) or close contact casting, in which a minimally padded 
cast was applied after closed fracture reduction by an orthopedic surgeon in an operating 
room under anesthesia. Data were collected at least 3 years after randomization using patient-
reported postal questionnaires. 
 
The primary outcome measure for the original trial was the Olerud and Molander Ankle 
Score (OMAS, range 0 to 100, higher scores indicating better ankle function) at 6 months3, 
with a pre-specified equivalence margin of ±6 points. Extended follow-up used the same 
primary outcome equivalence margin and assessed as secondary outcomes; quality of life, 
pain, and a post-hoc analysis of additional operations after 6 months (Table 1). Per-protocol 
primary analysis was used, consistent with the main trial.1 Random-effects models estimated 
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mean differences and 95%CIs between treatments adjusted for age, sex, fracture pattern, 
baseline score, and time to follow-up, including the center variable as a random effect. The 
random-effects model was also used post hoc to assess differences in OMAS for participants 
with vs without radiological malunion and non-union at six months. Change from baseline 
score was analyzed for outcomes with a non-normal distribution. The primary outcome at 
extended follow-up assessed equivalence with the null hypothesis that the two groups were 
not equivalent. For all other outcomes,  tests were two-sided at the 5% significance level. 
Analyses were conducted with Stata v.15.0. 
 
Results 
Between September 2013 and November 2016, 450 of the 620 randomized participants 
(73%) responded to follow-up at median 3 (range 2.9 to 9.5) years. Responders and non-
responders had similar characteristics (Table 1). Most responders lived in their own home 
(209 of 222 surgery [94%], 196 of 206 casting [95%]). 
 
Surgery and casting participants had equivalent ankle function (OMAS mean surgery 79.4, 
casting 76.3, difference -1.3, 95%CI: -5.6 to 3.0) and no significant differences in quality of 
life or pain (Table 2). Twenty-two of 222 surgery (10%) and 17 of 206 casting participants 
(4%) had operations after 6 months, including surgical implant removals (15 surgery [7%] 
and 8 casting [8%]), arthrodesis (1 surgery [0.5%] and 3 casting [1.5%]), arthroplasty (1 
surgery [0.5%] and 1 casting [0.5%]), and infection-related procedures (2 surgery [1%] and 0 
casting). Five casting participants (2%) had internal fixations for non-union after 6 months. 
There was one internal fixation revision, one arthroscopy, and one hindfoot osteotomy among 
surgery participants. In post hoc analysis, from randomization to extended follow-up, total 
operating room procedures per participant (per protocol) were mean 1.2 (SD 0.5) for surgery 
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and 1.3 (0.6) for casting, and surgical procedures, 1.2 (0.5) for surgery and 0.3 (0.6) for 
casting.   
 
Of 67 participants with radiological abnormalities at 6 months, 43 provided extended follow-
up data. Those with malleolar malunion at 6-months had significantly lower OMAS scores 
(n=30, mean [SD]: 58.7 [33.1]) compared to those without (n=372, mean [SD]: 79.8 [23.5]; 
mean difference -16.4 [95%CI: -25.0, -7.8]; p<0.001).  Participants with medial malleolar 
non-union at 6-months also had significantly lower OMAS scores (n=13, mean [SD]: 55.4 
[38.5]) compared to those without (n=388, mean [SD]: 79.1 [23.9]; mean difference -13.9 
[95%CI: -26.6, -1.2]; p=0.032). Treatment was not a significant covariate in these analyses.  
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Discussion 
Equivalence in function between casting and immediate surgery strategies was maintained at 
3 years.  In post hoc analyses, participants with radiological malunion and medial malleolar 
non-union at 6 months had lower OMAS scores at three-year follow-up.  These longer-term 
outcomes will support surgeon and patient decision-making.  The findings indicate that 
treatment of ankle fractures in older adults should focus on obtaining and maintaining a 
reduction until union, by the most conservative means possible.  
 
The study was limited by its reliance on self-reported events requiring participant recall and 
by loss to follow-up. However, there were sufficient data to estimate and conclude 
equivalence in the primary outcome. 
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Table 1. Baseline demographics and clinical characteristics of responders and non-
responders at extended follow-up 
 Responders 
(n=450) 
Non-responders 
(n=170) 
Characteristics Surgery  
(n=226) 
Casting 
(n=224) 
Surgery  
(n=83) 
Casting 
(n=87) 
Age, mean (SD), y  68.5 
(6.2) 
70.7 (7.1) 73.6 
(7.6) 
73.5 
(8.5) 
Sex, No. (%)     
Male 63 
(27.9) 
56 (25.0) 19 (22.9) 22 
(25.3) 
Female 163 
(72.1) 
168 (75.0) 64 (77.1) 65 
(74.7) 
Ankle fracture classification, No. (%)     
Infrasyndesmotic/trans-syndesmotic 197 
(87.2) 
192 (85.7) 75 (90.4) 78 
(89.7) 
Suprasyndesmotic 29 
(12.8) 
32 (14.3) 8 (9.6) 9 (10.3) 
Olerud-Molander Ankle Score, preinjury, 
mean (SD)a,b  
91.2 
(16.3) 
89.7 (16.8) 86.1 
(18.4) 
82.4 
(18.9) 
SF-12 mental score preinjury, mean 
(SD)a,c 
54.0 
(7.8) 
55.1 (7.1) 53.1 
(8.8) 
52.9 
(8.2) 
Missing data 1 0 1 0 
SF-12 physical score preinjury, mean 
(SD)a,c 
51.8 
(8.4) 
50.6 (9.9) 49.3 
(9.6) 
47.0 
(11.1) 
Missing data 1 0 1 0 
EQ-5D score preinjury, mean (SD)a,d,e 0.91 
(0.17) 
0.89 (0.17) 0.89 
(0.15) 
0.83 
(0.23) 
Missing data 20 17 11 13 
EQ-5D score day of randomization, mean 
(SD)d,e 
0.06 
(0.25) 
0.08 (0.25) -0.01 
(0.27) 
0.03 
(0.26) 
Missing data 32 29 17 18 
Mini-Mental State Examination score, 
mean (SD)d 
28.4 
(1.9) 
28.2 (2.1) 27.4 
(2.5) 
27.1 
(2.8) 
Missing data 20 17 12 13 
Medical history, No. (%)     
Heart disease 29 
(12.8) 
30 (13.4) 9 (10.8) 14 
(16.5) 
Non-insulin-dependent diabetes  20 (8.9) 17 (7.6) 11 (13.3) 9 (10.6) 
Cerebrovascular accident/transient 
ischemic attack 
10 (4.4) 12 (5.4) 4 (4.8) 9 (10.6) 
Osteoarthritis 55 
(24.3) 
70 (31.3) 29 (34.9) 30 
(35.3) 
Depression 24 
(10.6) 
26 (11.6) 11 (13.3) 12 
(14.1) 
Clinical outcomes at 6 Months     
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Olerud-Molander Ankle Score, n; mean 
(SD)b  
225; 
67.6 
(20.3) 
224; 65.7 
(22.2) 
73; 61.2 
(23.6) 
70; 61.4 
(22.7) 
Missing data 1 0 0 1 
SF-12 mental score, n; mean (SD)c 225; 
52.9 
(9.7) 
224; 53.0 
(9.4) 
73; 49.1 
(12.2) 
70; 49.7 
(10.2) 
Missing data 1 0 0 1 
SF-12 physical score, n; mean (SD)c 225; 
46.4 
(9.7) 
224; 45.2 
(10.2) 
73; 43.1 
(10.7) 
70: 41.2 
(11.3) 
Missing data 1 0 0 1 
Abbreviations: EQ-5D, EuroQol 5 dimensions questionnaire4; IQR, interquartile range; SF-
12, 12-item Short Form health survey5 
a Participants recalled preinjury status. 
b Range 0 to100, with higher scores indicating better ankle function. 
c Range 0 to 100, with higher scores indicating better functioning. 
d The majority of missing scores relate to early study participants, before the measure was 
introduced.  
e Range typically from 0 (death) to 1 (perfect health); negative scores can be obtained, 
reflective of a patient’s quality of life being worse than death. 
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Table 2. Primary and secondary outcomes at extended follow-up (per-protocol analysis) 
 Surgery  
 
Casting 
 
 
Measure No. Mean (95% CI) No. Mean (95% CI) Adjusted difference (95% 
CI)a 
Olerud-Molander Ankle Scoreb 220 79.4 (76.3 to 
82.5) 
203 76.3 (72.7 to 79.9) -1.3 (-5.6 to 3.0) 
SF-12 mental scorec 204 51.9 (50.7 to 
53.2) 
190 52.7 (51.3 to 54.0) 0.5 (-1.2 to 2.2) 
SF-12 physical scorec 204 47.2 (45.8 to 
48.7) 
190 44.7 (42.9 to 46.4) -0.8 (-2.6 to 1.1) 
EQ-5D scored (change from baseline)   187 -0.75 (-0.79 to -
0.71) 
177 -0.68 (-0.74 to -
0.63) 
0.04 (-0.01 to 0.09) 
Olerud-Molander Ankle Score pain ratinge 221 1.8 (1.7 to 1.9) 205 1.9 (1.8 to 2.1) 0.09 (-0.1 to 0.3) 
EQ-5D score pain ratingf   219 1.5 (1.4 to 1.6) 205 1.5 (1.5 to 1.6) 0.05 (-0.1 to 0.2) 
Abbreviations: EQ-5D, EuroQol 5 dimensions questionnaire; SF-12, 12-item Short Form health Survey. 
a Differences were adjusted for baseline outcome values, age, sex, recruitment hospital, fracture pattern (trans-syndesmotic and 
Infrasyndesmotic vs suprasyndesmotic) and time to follow-up. 
b Range 0 to100, with higher scores indicating better ankle function. 
c Range 0 to 100, with higher scores indicating better functioning. 
d Range typically from 0 (death) to 1 (perfect health); negative scores can be obtained, reflective of a patient’s quality of life being worse than 
death. 
e Scores were from 1 to 5, with 1 indicating “non” and 5 indicating “constant and severe”.  
f Score were from 1 to 3, with 1 indicating “no pain or discomfort” and 3 indicating “extreme pain or discomfort”.  
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